DURHAM, NC - Eleven-year-old, venture-backed drug discovery company Scynexis Inc. has raised $5.5 million, or 36 percent, of a targeted $15 million stock and debt offering to investors.
Nine investors have taken part in the offering to date, the first says in a new filing with the U.S. Securities and Exchange Commission.
(more…)
ORLANDO, FL - A Central Florida initiative to support local entrepreneurs has selected two high-technology companies as the winners of its first $200,000 seed-capital sweepstakes.
The Florida IDEA Grant Program chose Pandora Genomics LLC of Orlando and Rillip Inc. of Edgewater to receive grants of as much as $50,000 each.
The companies — one a biotech startup, the other an online data-mining firm — will also receive in-kind services such as accounting, marketing and legal assistance valued at as much as $50,000 each, program officials said this week.
(more…)
RALEIGH, NC - Early-stage life science companies have long grumbled about the ability to secure financing and those grumbles have only grown louder given the market conditions that have dried up many financing options.The state of North Carolina will now provide another way for life science companies to slake their thirst for capital. State Treasurer Janet Cowell will invest up to $35 million from the state’s pension fund to support early-stage life science companies in the state. Cowell formally announced the “Accelerator” at the Southeast BIO Investor Forum in Durham, North Carolina today.
(more…)
ATLANTA, GA - An Atlanta-based medical device maker has raised more than half of a planned $1 million raise, according to a Securities & Exchange Commission filing.Scientific Intake has developed a weight loss product that helps people eat slower, thereby eating less.
People eat too quickly and eat too much before they feel full - or satisfied.
(more…)
CORAL GABLES, FL - Coral Gables-based Catalyst Pharmaceutical Partners Catalyst Pharmaceutical PartnersLatest from The Business JournalsFind out which South Florida stocks took the worst poundingCatalyst Pharmaceutical to sell 2.26M sharesCatalyst launches M clinical trialFollow this company said it plans to launch a $3.5 million stock offering, but its share price reacted negatively after the announcement.
The developmental-stage company (NASDAQ: CPRX) said it would sell 3.05 million shares of its common stock plus warrants to purchase an additional 1.52 million shares of its common stock. The price is $1.15 a share.
(more…)
CHAPEL HILL, N.C. — Cempra Holdings, LLC, the parent holding company of Cempra Pharmaceuticals, Inc., today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to its proposed initial public offering.
Stifel Nicolaus Weisel, Leerink Swann LLC and Cowen and Company are serving as joint book-running managers for the offering. Needham & Company, LLC is acting as co-manager.
http://www.prnewswire.com/news-releases/cempra-holdings-llc-files-registration-statement-for-proposed-initial-public-offering-131628393.html
SUNRISE, FL - Bioheart BioheartLatest from The Business JournalsHot LeadsBioheart terminates AnC Bio’s .6M investmentBioheart secures M investmentFollow this company announced a deal to raise $3 million by selling its common stock over the next two years.
The Sunrise-based development stage biotechnology company (OTCBB: BHRT) is working on clinical trials for its MyoCell product, a potential stem cell treatment for heart disease. It did not name the investor who agreed to buy its stock.
(more…)
ATLANTA, GA - A Marietta-based based medical device company that focuses on catheter technologies has raised $2.35 million, according to a Securities and Exchange Commission Securities and Exchange CommissionLatest from The Business JournalsHCA to offer 0 million in notesRBC pays million to SEC in Stifel-Wisconsin flapAmerican Airlines to raise 5 million in debtFollow this company filing.
Atlanta Catheter Therapies Inc. has a portfolio of catheter technologies for the treatment of vascular disease and restenosis.
(more…)
ATLANTA, GA -GeoVax Labs Inc. GeoVax Labs Inc.Latest from The Business JournalsNew institute focusing on repairing the bodyGeoVax gets .6M IPCAVD grantGeoVax records 1,000 Q2 lossFollow this company’s recent $3.6 million Integrated Preclinical/Clinical AIDS Vaccine Development grant has been boosted to $4.4 million.
(more…)
ATLANTA, GA - Metabolon, Inc., a diagnostics and services company offering the industry’s leading biochemical profiling technology, announced today that it has secured $13.1 million in a Series D financing.
(more…)
